Current market price of sarepta therapeutics
WebSarepta Therapeutics Inc. stock slid 6.4% Thursday, after a news report cast uncertainty over the path to regulatory approval for the company’s SRP-9001 gene therapy for a rare genetic disorder ... WebApr 10, 2024 · The average twelve-month price prediction for Sarepta Therapeutics is $167.11 with a high price target of $206.00 and a low price target of $122.00. Learn …
Current market price of sarepta therapeutics
Did you know?
WebFind the latest Sarepta Therapeutics, Inc. (SRPT) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Market Cap: 12.113B: … WebSarepta Therapeutics stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. ... Price/Book: A financial ratio used to compare a company's current market price to its book value. Price/Earnings: Latest closing price divided by the earnings-per-share based on the trailing 12 months ...
WebAccording to our current SRPT stock forecast, the value of Sarepta Therapeutics shares will drop by -26.21% and reach $ 101.74 per share by April 5, 2024. According to our technical indicators, the current sentiment is Bullish while the Fear & Greed Index is showing 39 (Fear).SRPT stock recorded 14/30 (47%) green days with 8.22% price … WebApr 13, 2024 · Oppenheimer cut their target price on shares of Sarepta Therapeutics from $180.00 to $150.00 and set an outperform rating for the company in a research report on …
WebSarepta Stock Has $30 to $40 Upside if Panel on Gene Therapy Drug Positive, Says Analyst 11/28/22 Barron's Sarepta's Gene Therapy Set for Quick FDA Review 07/29/22 Barron's Sarepta Will Seek...
WebNov 23, 2004 · Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced that the date of the U.S. Food and Drug Administration’s Cellular, Tissue ...
WebMar 23, 2024 · Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat S&P 500 3,977.53 DOW 32,432.08 QQQ 308.76 Should You Buy Before the Ex-Dividend Date or Wait? My No. 1 dividend stock for a LIFETIME of income. (Ad) Dividends, Short-Term Pain, but Long … hobby stores kansas city moWebSep 14, 2024 · Sarepta Therapeutics Prices $1.0 Billion of Convertible Sarepta Therapeutics Prices $1.0 Billion of Convertible Senior Notes Due 2027 With current … hslf 2022:49WebSarepta Therapeutics (SRPT) Try Excel Alerts Watch Help Go To: Full Chart Realtime quote and/or trades are not sourced from all markets. Fundamentals Market … hobby stores los angelesWeb1 day ago · Published: April 13, 2024 at 2:27 a.m. ET. The Readers in the section will understand how the Cancer Cachexia Therapeutics market scenario changed across the globe during the pandemic, post ... hslf 2021:75Web1 day ago · Sarepta Therapeutics stock price target raised to $180 from $150 at Oppenheimer Mar. 1, 2024 at 8:08 a.m. ET by Tomi Kilgore Sarepta stock surges more than 10% as results top expectations,... hsl factsheetWebApr 13, 2024 · SRPT stock closed at $137.68 and is down -$9.26 during pre-market trading. Pre-market tends to be more volatile due to significantly lower volume as most investors … hslf 2022:39Web19 hours ago · Mizuho maintains its Buy rating with a price target of $160.00. Price Action: SRPT shares are down 7.03% at $128.00 on the last check Thursday. SHARE THIS POST hsl failed to add payment card